Navigation Links
Safety data favor norepinephrine over dopamine for shock
Date:3/3/2010

ATLANTA - Physicians treating patients with shock should consider norepinephrine instead of dopamine as a tool for stabilizing blood pressure, according to an editorial in the March 4, 2010, issue of the New England Journal of Medicine (NEJM).

Jerrold Levy, MD, FAHA, professor and deputy chair for research, Department of Anesthesiology, Emory University School of Medicine, and co-director of cardiothoracic anesthesiology, Emory Healthcare, authored the editorial.

The editorial accompanies a report in the same issue of NEJM on a European clinical trial evaluating dopamine and norepinephrine in shock patients. The randomized trial, led by Daniel De Backer, MD, PhD, at Erasme University Hospital in Belgium, compared 28-day mortality in 1679 patients treated for shock with dopamine or norepinephrine in Austria, Belgium and Spain between 2003 and 2007.

"Dopamine has been commonly used as a first-line therapy for shock at many hospitals for years, partially because of the widespread perception that norepinephrine is associated with adverse events," Levy says. "The current study supports the concept that shock from any cause carries a high risk of death, and raises significant concerns about the safety of dopamine."

Shock, or dangerously low blood pressure, can occur as a result of sepsis (severe inflammation resulting from bacterial infection), heart failure (cardiogenic), hemorrhage (severe blood loss) or anaphylaxis. Most of the patients (62.2 percent) in the European trial had septic shock, 16.7 percent had heart failure and 15.7 percent hemorrhage.

The authors of the clinical study reported no overall difference in death rates at 28 days. However, heart arrhythmias were almost twice as common in the dopamine group (24.1 percent vs 12.4 percent) and mortality was higher for patients with cardiogenic shock treated with dopamine.

A previous observational study showed that dopamine's use in intensive care units added to the risk of death, and rapid heart rate is known to be a frequent side effect of dopamine, Levy notes.

Norepinephrine has been used to stabilize patients' blood pressure during cardiac and non cardiac surgery, and in intensive care units after surgery. Vasopressin, although not studied in the European clinical trial, is also a viable alternative treatment for shock, Levy says.

The hormones dopamine and norepinephrine have functions in the brain, helping neurons communicate, as well as in the body to maintain vascular tone. In an emergency situation, they both can increase blood pressure by constricting blood vessels. Dopamine is the precursor to norepinephrine in the sympathetic nervous system, and thus acts indirectly.

"The data challenge consensus guidelines that recommend dopamine as the initial vasopressor for increasing arterial pressure in the case of septic shock or cardiogenic shock," Levy writes in the editorial.

"In addition, norepinephrine needs to be considered as an initial therapeutic agent for patients in circulatory shock. The results of the study by De Backer et al should also put an end to the outdated view that the use of norepinephrine increases the risk of death."


'/>"/>

Contact: Lance Skelly
lskelly@emory.edu
404-686-8538
Emory University
Source:Eurekalert

Related medicine news :

1. FDA, FSIS, CDC Collaborate on Methods to Measure Success of Food Safety Programs
2. MainStreet MD Launches Personal Safety Solutions for Children and Seniors Built On SensorLogic's Cloud Computing Platform
3. Brain Injury Association of Washington Provides National Leadership in Concussion Safety & Awareness
4. Occupational Health Expert Expands PureSafety's Growing Strategic Resources Team
5. Surgical Information Systems Introduces SIS OR View to Maximize Communication and Improve Patient Safety in the Operating Room
6. Food Safety Attorney Fred Pritzker Calls on Food Retailers to Keep Precise Beef Handling Records
7. American Stroke Association Late-Breaking Science Report: Surgery, Stenting to Open Blocked Neck Arteries Similar in Safety, Efficacy, But Show Differences in Stroke, Heart Attack and Death Rates at Certain Ages
8. Toyota Recalls Raise Awareness of Vehicle Safety Issues, Risks of Accidents from Driving Defective Automobiles
9. The Coalition for Vaccine Safety Calls for Congressional Hearings on Federal Agencies Failure to Provide Adequate Safety Research
10. Bitrex Bitter Safety Additive Exhibiting at the Safe Kids Fair 2010; Making a Bitter Face to Learn about Poisoning Prevention
11. Tests to Measure Safety of Anti-Clotting Drugs of Limited Value
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... July 27, 2017 , ... Healthy eating isn’t always easy. Currently, more than 80 percent of ... many Americans overeat refined grains and sugar. This trend may help explain why the obesity ... U.S. are obese. , As a culture, we seem to have food on the brain ...
(Date:7/27/2017)... ... July 27, 2017 , ... The Freedom from Cancer Startup ... around 117 breakthrough inventions from 55 institutions, including the National Institutes of Health ... Biomedical Imaging and Bioengineering), the United States Army, and more than fifty American ...
(Date:7/27/2017)... GREENWOOD VILLAGE, CO (PRWEB) , ... July 27, 2017 , ... ... According to the National Funeral Directors Association, this trend is expected to continue with ... this trend, there is a growing demand for new innovations that enable families to ...
(Date:7/26/2017)... ... July 26, 2017 , ... An inventor from Salisbury, N.C., knows the ... seen an effective and dignified way to keep leeches in place during therapy," she ... This invention provides an effective way to keep a leech in place on the ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley ... major advancement in drug therapy for patients living with relapsing and primary multiple ... novel B cell targeted therapy that has been proven to significantly reduce signs ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... is a revolutionary new product that relieves painful carpal tunnel syndrome ... affects more than 8 million people a year. Women suffer from ... methods of treating CTS are painful surgery, the use of NSAIDs ... ... a clear patch worn on the palm of the hand. It ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known ... that can quantify biological aging in a precise manner using the myDNAge ... Steve Horvath , a professor of human genetics and biostatistics at the ... School of Public Health , Zymo Research,s proprietary DNAge ™ technology ... ...
(Date:7/11/2017)... Md. , July 11, 2017  The global ... estimated revenues of approximately $394.1 million in 2016.  Although ... trend of solid growth, in particular as a result ... clinical practice, and the recent introduction of a significant ... need for less-invasive testing of tumor biomarkers to guide ...
Breaking Medicine Technology: